Question: What is the vascular toxicity commonly associated with platinum based chemotherapy?
Answer: The cited reference reports on a large group of patients receiving platinum based chemotherapy for bladder cancer. These authors concluded “Patients receiving platinum based chemotherapy were at higher risk for thromboembolism but not other vascular events, particularly in the first year after diagnosis. This risk of thromboembolism is similar for cisplatin and carboplatin.”
Posted in Question Of The Day